HCM · NASDAQ · Drug Manufacturers - Specialty & Generic

HUTCHMED (ADR) (HCM)

Develops targeted therapies and immunotherapies, commercializing medicines in China and through global partners.

$14.20
vs last close+0.13 (+0.92%)
  1. Syndio Acquires Embrace.ai

    Business Wire